ED Observation for Opioid Use Disorder
Key facts
- Who runs it
- NYU Langone Health
- Where
- Brooklyn, New Hyde Park, New York, Newark, and Staten Island, United StatesSee the 6 sites
- Trial code
- Status
- Completed
- People taking part
- 170 people enrolled
- Started
- 21 Apr 2022
- Ended
- 31 Jul 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Extended Visit with Observation
- Standard ED Visit
- Record updated
- 3 November 2026
Who can take part
- Age
- 18 years to 100 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (13)Hide the full registry criteria
Who can take part
- Is 18 years of age or older
- Is able to speak English sufficiently to understand study procedures
- Has a history of non-medical opioid use
- Is a potential candidate for ED-based MOUD treatment initiation and referral at the site as confirmed by clinical staff
- s not receiving MOUD through ongoing formal addiction treatment or pain management at the time of index ED visit
- Is willing to receive either standard ED care or enhanced ED care in EDOU depending on random assignment
- Presents to the ED during study screening hours
Who cannot take part
- Unwilling or unable to provide written/electronic informed consent/HIPAA Authorization for research procedures, including research visits at baseline and Day 30 and Day 90, and/or consent for the release of health records and data matching for a period of 2 years following enrollment and 1 year prior to enrollment
- Previous participation in the current study
- Has acute, severe medical, psychiatric, or concurrent substance use problem or meets other criteria that would exclude the patient (clinically) from placement in EDOU according to EDOU placement clinical protocols
- Currently in jail, prison or any inpatient overnight facility as required by court of law or have pending legal action or that could prevent participation in the study
- Presents from a medical-based extended care facility (e.g., skilled nursing facility)
- Inadequate locator information (unable or unwilling to provide one unique mean of contact)
Where in United States
- NYULH-BrooklynBrooklyn, United States
- Northwell Health/Long Island Jewish Medical CenterNew Hyde Park, United States
- BellevueNew York, United States
- NYULH-TischNew York, United States
- Rutgers University-University HospitalNewark, United States
- Northwell Health- Staten Island University HospitalStaten Island, United States
About the trial
What the trial wants to find out
This is a multicenter, randomized clinical comparative effectiveness trial (RCT) in which patients with untreated OUD presenting to a Northwell Health Emergency Department (ED), NYULH-Brooklyn, NYULH-Tisch, and Bellevue Hospital will be randomized (1:1) to be managed clinically through either a standard ED visit or an extended visit through ED observation (EDOU).
The 2 groups in the trial
- Standard visitExisting treatment, for comparison
Participants will have standard Emergency Department visit as per standard operating procedures which should last approximately 3 -5 hours.
Treatment: Standard ED Visit
- Extended visit with ObservationTreatment being tested
Participants will have extended Emergency Department visit by having an observation (which could be up to 23 hours) time in addition to the standard ED visit. In addition, information will be gathered about about the participants, use of opioids, healthcare visits, the quality of health, life, and treatment, and other topics. Urine or saliva or both may also be collected.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Measuring Improvement in the Quality of Emergency Department-initiated Treatment for Opioid Use Disorders Using Observation
- Record updated
- 3 November 2026